And who made comments on Anita Monteith & MontRidg

Quote:

---

“MontRidge’s seasoned professionals bring a wealth of experience and an extensive network of personal contacts to the investor relations arena. Their personalized approach to targeting combines experience, intuition and a keen sense of timing to match biotech companies to prospective investors. Their track record and detailed knowledge of the biotech sector have earned them an impressive reputation on the Street.”

- Gail Maderis, Ph.D., CEO, Five Prime Therapeutics, Inc.

“MontRidge has provided PolyMedix with absolutely outstanding investor relations support. The MontRidge team is highly experienced, very knowledgeable about the biotechnology markets and equally adept at providing both tactical support as well as critical strategic thinking and planning. They are responsive, conscientious, perceptive, creative and very hard working. I consider them to be the very best biotechnology investor relations experts for small, emerging companies.”

- Nicholas Landekic, President and CEO, PolyMedix, Inc.

“We at IDEC have greatly valued our relationship with MontRidge, LLC for the better part of a decade. MontRidge has met the requirements of IDEC as we have grown from a micro-cap biotechnology firm to a successful pharmaceutical company. We have experienced significant benefits from the highly personalized investor relations style and concentrated effort MontRidge has made on our behalf.”

- William Rastetter, Ph.D., Chairman and CEO, IDEC Pharmaceuticals

---